- $10.73bn
- $10.42bn
- $738.26m
U.S. RESEARCH ROUNDUP-Bankunited, Chevron, Paychex
Biotech firm Repligen beats Q3 revenue estimates, raises guidance
Life sciences firms climb after Pfizer drug pricing agreement with US government
U.S. RESEARCH ROUNDUP-Adobe, Nextdecade, United Airlines
Brief: Repligen Announces Strategic Partnership With Novasign To Further Advance Bioprocessing Digitalization
U.S. RESEARCH ROUNDUP-Penumbra, UnitedHealth, Visa
Repligen Corp reports results for the quarter ended June 30 - Earnings Summary
Life sciences firm Repligen beats Q2 revenue estimates, raises full-year guidance
Repligen Corp reports results for the quarter ended March 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Blue Owl Capital, Insulet, Unity Software
U.S. RESEARCH ROUNDUP-Blue Owl Capital, Insulet, Unity Software
U.S. STOCKS ON THE MOVE-Repligen, Mangoceuticals, Insmed
U.S. STOCKS ON THE MOVE-Sabre, MicroStrategy, Repligen
Repligen jumps on strong annual forecast and quarterly results beat
Repligen Corp reports results for the quarter ended December 31 - Earnings Summary
10x Genomics, Quanterix worst-hit if US health agency cuts costs, Leerink says
U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart
U.S. STOCKS ON THE MOVE-Canadian National Railway, C.H. Robinson, Meta
U.S. STOCKS ON THE MOVE-Honeywell, Canadian National Railway, C.H. Robinson